You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alpha lipoic acid

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")

Not yet recruiting
  • Ulcerative Colitis
  • "Mesalamine" and "alpha-lipoic acid"
  • "Mesalamine" and "Placebo"
  • (no location specified)
Oct 5, 2023

Postoperative Atrial Fibrillation Trial in Cairo (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo)

Not yet recruiting
  • Postoperative Atrial Fibrillation
  • Alpha Lipoic Acid 600 MG Oral Tablet
  • Placebo
  • Cairo, Egypt
    Ain shams university
Nov 21, 2023

Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)

Recruiting
  • Ischemic Cardiomyopathy
  • Diabetes Mellitus
  • Alpha Lipoic Acid 600 MG Oral Tablet
  • Placebo Tablet
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Sep 26, 2023

DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)

Not yet recruiting
  • Diabetes MellitusType 1
  • Placebo
  • Alpha Lipoic Acid 600 MG Oral Capsule
  • (no location specified)
Jan 8, 2023

Sepsis Trial in Cairo (Alpha-Lipoic Acid, Sepsis Supportive Care)

Recruiting
  • Sepsis
  • Alpha-Lipoic Acid
  • Sepsis Supportive Care
  • Cairo, Egypt
    Ain Shams University Specialized Hospital
Mar 30, 2023

Nutrition, Healthy Trial (GCE + Low ALA, GCE + High ALA, Placebo)

Not yet recruiting
  • Nutrition, Healthy
  • GCE + Low ALA
  • +2 more
  • (no location specified)
Nov 7, 2023

Peripheral Diabetic Neuropathy Trial in Peshawar (Resveratrol, Alpha lipoic acid, Super oxide dismutase, Resveratrol, Alpha

Active, not recruiting
  • Peripheral Diabetic Neuropathy
  • Resveratrol, Alpha lipoic acid, Super oxide dismutase
  • +3 more
  • Peshawar, KPK, Pakistan
    Syed Hamid Habib
Nov 12, 2023

Insulin Resistance, Obesity Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Placebo,

Not yet recruiting
  • Insulin Resistance
  • Obesity
  • Placebo
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 10, 2023

Burning Mouth Syndrome Trial in Catania (Lipoid acid gel, Placebo)

Recruiting
  • Burning Mouth Syndrome
  • Lipoid acid gel
  • Placebo
  • Catania, Italy
    AOU Policlinico G. Rodolico
Feb 6, 2023

Vestibular Function Disorder Trial in San Antonio (Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg)

Not yet recruiting
  • Vestibular Function Disorder
  • Alpha Lipoic Acid 300mg
  • Coenzyme Q10 200mg
  • San Antonio, Texas
    University of Texas Health Science Center at San Antonio
Jul 5, 2023

Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)

Recruiting
  • Metabolic Associated Fatty Liver Disease
  • LUDLEV®300 mg/46.2 mg
  • Placebo
  • Mexico, Veracruz, Mexico
    Ana Delfina Cano Contreras
Jun 12, 2023

Polyneuropathy, Diabetic Trial in Egypt (Alpha-Lipoic Acid (ALA), Placebo)

Recruiting
  • Polyneuropathy, Diabetic
  • Alpha-Lipoic Acid (ALA)
  • Placebo
  • Alexandria, Bab Sharqi, Egypt
  • +4 more
Apr 3, 2023

Schizophrenia, Oxidative Stress Trial in Fortaleza (Alpha-lipoic acid, Placebo Oral Tablet)

Completed
  • Schizophrenia
  • Oxidative Stress
  • Alpha-lipoic acid
  • Placebo Oral Tablet
  • Fortaleza, CE, Brazil
    Núcleo de Pesquisa e Desenvolvimento de Medicamentos - UFC
Aug 26, 2022

HNSCC Trial in Aurora (Alpha Lipoic Acid)

Recruiting
  • HNSCC
  • Alpha Lipoic Acid
  • Aurora, Colorado
    Abigail E Berry
May 12, 2022

Low-Grade Squamous Intraepithelial Lesions Trial in Tuzla, Zagreb (DL-alpha lipoic acid, (rice starch))

Completed
  • Low-Grade Squamous Intraepithelial Lesions
  • DL-alpha lipoic acid
  • placebo (rice starch)
  • Tuzla, Bosnia and Herzegovina
  • +1 more
Jul 31, 2022

Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500

Recruiting
  • Pancreas Adenocarcinoma
  • CPI-613® (Dose level -1.0 250 mg/m^2)
  • +6 more
  • Detroit, Michigan
  • +1 more
Nov 9, 2022

Clomiphene Citrate, Resistant Ovary Syndrome, Polycystic Ovary Syndrome Trial in Bani Suwayf, Giza (Alpha lipoic acid (ALA),

Recruiting
  • Clomiphene Citrate
  • +2 more
  • Alpha lipoic acid (ALA)
  • +2 more
  • Banī Suwayf, Egypt
  • +2 more
Jan 1, 2023

Atherosclerosis Trial in Portland (R-alpha lipoic acid)

Active, not recruiting
  • Atherosclerosis
  • R-alpha lipoic acid
  • Portland, Oregon
    Oregon Health & Science University
Apr 19, 2022

Atherosclerosis Trial in Portland (R-alpha lipoic acid, Placebo)

Active, not recruiting
  • Atherosclerosis
  • R-alpha lipoic acid
  • Placebo
  • Portland, Oregon
    Oregon Health & Science University
Apr 19, 2022

No-Reflow Phenomenon Trial (Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI)

Not yet recruiting
  • No-Reflow Phenomenon
  • Alpha Lipoic Acid plus the standard care for post-PCI MI
  • The standard care for post-PCI MI
  • (no location specified)
Apr 29, 2022

G6PD Deficiency, Carbohydrate Metabolism Disorder, Oxidative Stress Trial (Alpha-lipoic acid, Placebo)

Not yet recruiting
  • G6PD Deficiency
  • +2 more
  • Alpha-lipoic acid
  • Placebo
  • (no location specified)
Jan 2, 2023

Antioxidative Stress, End Stage Renal Disease on Dialysis Trial in Cairo (Alpha lipoic acid, Selenium)

Completed
  • Antioxidative Stress
  • End Stage Renal Disease on Dialysis
  • Cairo, Egypt
    Ain Shams University
Mar 1, 2022

Healthy Trial (200mg GCE +200mg ALA, 200mg GCE +400mg ALA, 200mg GCE + 200mg DHB)

Not yet recruiting
  • Healthy
  • 200mg GCE +200mg ALA
  • +3 more
  • (no location specified)
Nov 13, 2023

Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)

Completed
  • Diabetic Neuropathies
  • +2 more
  • Epineuron
  • Placebo group
  • Thessaloníki, Thessaloniki, Greece
    University General Hospital AHEPA
Aug 8, 2023

Breast Cancer, Chemotherapeutic Toxicity Trial in Tanta (Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as

Completed
  • Breast Cancer
  • Chemotherapeutic Toxicity
  • Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
  • Placebo Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
  • Tanta, Gharbia, Egypt
    Tanta Oncology Center
Oct 4, 2021